Results 191 to 200 of about 4,977,677 (230)
Some of the next articles are maybe not open access.

Palliative electrochemotherapy in primary or recurrent vulvar cancer

International Journal of Gynecological Cancer, 2020
Objective Since vulvar cancer is such a rare disease, the international experience with electrochemotherapy has been derived from only a few centers.
G. Corrado   +10 more
semanticscholar   +1 more source

Management of vulvar cancer

Cancer, 1995
Current therapy of vulvar malignancies is reviewed with emphasis on screening, etiology, diagnosis, staging, and treatment of preinvasive and invasive cancer.Screening procedures, etiologic possibilities, diagnostic techniques, staging implications, and treatment approaches are discussed in detail.All malignancies of the vulva should be detected at an ...
openaire   +2 more sources

Multidisciplinary personalized approach in the management of vulvar cancer – the Vul.Can Team experience

International Journal of Gynecological Cancer, 2020
Introduction Multidisciplinary treatment strategy involving adjuvant radiotherapy for advanced vulvar cancer could be useful in offering the best personalized clinical approach.
L. Tagliaferri   +17 more
semanticscholar   +1 more source

Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate?

Gynecologic Oncology, 2020
PURPOSE GOG 205 safely increased clinical (cCR) and pathologic complete response (pCR) in locally-advanced vulvar cancer through dose escalation using three-dimensional radiotherapy (RT).
A. Richman   +11 more
semanticscholar   +1 more source

Patient reported outcome measures among patients with vulvar cancer at various stages of treatment, recurrence, and survivorship.

Gynecologic Oncology, 2020
OBJECTIVE Our goal was to pragmatically describe patient reported outcomes (PROs) in a typical clinic population of vulvar cancer patients, as prior studies of vulvar cancer PROs have examined clinical trial participants.
S. Alimena   +10 more
semanticscholar   +1 more source

Age-associated trends of vulvar cancer in the US.

Menopause, 2020
OBJECTIVE Medical societies have over the years moved away from recommending routine pelvic examinations in older, asymptomatic women above age 65. Consequently, vulvar examination is a largely neglected component of the physical examination, unless sent
H. Khadraoui   +4 more
semanticscholar   +1 more source

Reducing the radicality of surgery for vulvar cancer: are smaller margins safe?

Minerva Ginecologica, 2020
INTRODUCTION Vulvar cancer accounts for ~4% of all gynaecological malignancies and the majority of tumours (>90%) are squamous cell (keratanising, ~60% and warty/basaloid, ~30%).
Sarah Milliken   +9 more
semanticscholar   +1 more source

The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis.

Gynecologic Oncology, 2019
The tumor suppressor proteins p16 and p53 have been suggested to have prognostic value in some human papillomavirus (HPV)-associated cancers, however, this has been less well established for vulvar cancer.
F. L. Sand   +4 more
semanticscholar   +1 more source

Superparamagnetic iron oxide: a novel tracer for sentinel lymph node detection in vulvar cancer

International Journal of Gynecological Cancer, 2020
Objectives Superparamagnetic techniques for sentinel lymph node (SLNs) biopsy in breast cancer is well recognized but remains novel in the literature in relation to early stage vulvar cancer.
Marcin A Jedryka   +3 more
semanticscholar   +1 more source

Detection of sentinel lymph node in vulvar cancer using ^99mTc-labeled colloid lymphoscintigraphy, blue dye, and indocyanine-green fluorescence: a meta-analysis of studies published in 2010–2020

Archives of Gynecology and Obstetrics, 2022
M. C. Di Donna   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy